Wang et al. introduced a trimethyl-locked quinone group sensitive to NQO1 into a BRD4-targeting PROTAC, masking its activity until NQO1 is present in tumor cells, which cleaves the quinone group and restores degradation capability. The gene discussed is NQO1; the disease is neoplasm.